Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2023-11-28

Clinical Trial Update: Selective Estrogen Receptor Modulators (SERMs) - A Potential Treatment for Psychotic Symptoms of Schizophrenia in Men? [Phase 4]

View source ↗

Summary

Phase 4 trial investigating selective estrogen receptor modulators (SERMs) as a potential treatment for psychotic symptoms in men with schizophrenia or schizoaf…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: The Alfred | Conditions: Schizophrenia, Schizoaffective Disorder | Phase 4 | Status: COMPLETED